Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Rank in Stocks #12599
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Share Price
$9.09
Last synced: 2023-06-23
Market Cap
$567.77M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade CTI BioPharma Corp. (CTIC)

Category

Stock split history for CTI BioPharma Corp. (CTIC)
CTI BioPharma Corp. stock (symbol: CTIC) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 31, 2026.
One CTIC share bought prior to Aug 31, 2026 would equal to 0 CTIC shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH